VeriMom¿Es barley sh-oligopeptide-1 seguro durante el embarazo?
No evidence of reproductive or developmental hazard was identified in authoritative sources. There is no harmonised CLP classification (ECHA Annex VI) for reproductive toxicity for 'barley sh-oligopeptide-1', no SCCS or CIR safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenicity or endocrine disruption in PubMed. Peptides of this type are large biomolecules with low systemic absorption after topical application, so exposure is expected to be negligible for pregnancy.
Pregnancy-safe products containing barley sh-oligopeptide-1
Related ingredients
Frequently asked questions
- ¿Es barley sh-oligopeptide-1 seguro durante el embarazo?
- No evidence of reproductive or developmental hazard was identified in authoritative sources. There is no harmonised CLP classification (ECHA Annex VI) for reproductive toxicity for 'barley sh-oligopeptide-1', no SCCS or CIR safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenicity or endocrine disruption in PubMed. Peptides of this type are large biomolecules with low systemic absorption after topical application, so exposure is expected to be negligible for pregnancy.
- ¿Es barley sh-oligopeptide-1 seguro durante la lactancia?
- No data indicate reproductive or lactation hazards. No harmonised classification or authoritative safety assessment (CIR/SCCS) indicates risk to breastfeeding; no peer‑reviewed evidence shows milk transfer or effects on lactation. Topical peptides are unlikely to achieve systemic levels sufficient to transfer into breast milk.
- ¿Es barley sh-oligopeptide-1 seguro para la piel del bebé?
- No evidence of developmental or dermal toxicity in infants. Mechanistic concerns are not documented. However, infants (0–3 yr) have a higher skin permeability and higher surface‑area‑to‑weight ratio, so exposure potential is higher than in adults; adult dermal absorption for large oligopeptides is expected to be negligible, but given immature barrier function a conservative exposure score of 1 is applied. No infant‑specific adverse reports were found.
- ¿Cómo puntúa VeriMom a barley sh-oligopeptide-1?
- VeriMom puntúa barley sh-oligopeptide-1 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a barley sh-oligopeptide-1 en el embarazo?
- Consulta nuestra lista de alternativas seguras a barley sh-oligopeptide-1 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.